Sienna Biopharmaceuticals, Inc.. (SNNA) NASDAQ

$0.14 0 (0.00%)

Market Cap: $4.20M

As of 12/16/19 12:00 AM EST. Market closed.

(SNNA)

Sienna Biopharmaceuticals, Inc.. (SNNA) NASDAQ

$0.14 0 (0.00%)

Market Cap: $4.20M

As of 12/16/19 12:00 AM EST. Market closed.

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by ... read more

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Frederick C. Beddingfield
Full Time Employees
58
URL
Address
30699 Russell Ranch Road, CA, Westlake Village, 91362.
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Frederick C. Beddingfield
Full Time Employees
58
CEO Compensation (Base)
$508,000
Address
30699 Russell Ranch Road, CA, Westlake Village, 91362.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$0.14
Days Range
$0 - $0
52 week range
$0.11 - $0.17
Volume
0
Avg. Volume (30 days)
13,315,740
Market Cap
$4.20M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,907,500
Open
$0
Previous Close
$0.14
Days Range
$0 - $0
52 week range
$0.11 - $0.17
Volume
0
Avg. Volume (30 days)
13,315,740
Market Cap
$4.20M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,907,500

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SIENNA BIOPHARMACEUTICALS, INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Azoy Alexander Chief Financial Officer Oct 02, 2019 Option Exercise $0.23 2,396 551 103,552 Oct 04, 2019, 02:10 PM
Stroehmann Diane See Remarks Jul 02, 2019 Option Exercise $0.76 4,095 3,112 168,545 Jul 03, 2019, 01:47 PM
Andrews Timothy K. General Counsel & Secretary Jul 02, 2019 Option Exercise $0.76 4,095 3,112 95,558 Jul 03, 2019, 01:42 PM
Lizzul Paul F. Chief Medical Officer Jul 02, 2019 Option Exercise $0.76 4,095 3,112 141,488 Jul 03, 2019, 01:39 PM
Beddingfield III Frederick President & CEO Jul 02, 2019 Option Exercise $0.76 17,063 12,968 817,599 Jul 03, 2019, 01:35 PM
Azoy Alexander Chief Financial Officer Jul 02, 2019 Option Exercise $0.76 1,552 1,180 35,948 Jul 03, 2019, 12:00 AM
ARCH Venture Partners X, LLC 10% Owner Feb 22, 2019 Buy $2.50 2,165,800 5,414,500 2,900,575 Feb 26, 2019, 09:08 PM
ARCH Venture Partners VIII, LLC 10% Owner Feb 22, 2019 Buy $2.50 2,165,800 5,414,500 2,900,575 Feb 26, 2019, 09:06 PM
Burow Kristina Director Feb 22, 2019 Buy $2.50 2,165,800 5,414,500 2,900,575 Feb 26, 2019, 09:03 PM
MORE ROBERT J Director Feb 22, 2019 Buy $2.50 100,000 250,000 255,942 Feb 26, 2019, 05:16 PM
Leonard Keith R Director Feb 22, 2019 Buy $2.50 100,000 250,000 100,000 Feb 26, 2019, 05:14 PM
Beddingfield III Frederick President & CEO Feb 22, 2019 Buy $2.50 40,000 100,000 831,662 Feb 26, 2019, 05:12 PM
Harris Todd Head of Corporate Development Apr 30, 2018 Sale $20.00 100 2,000 570,991 May 02, 2018, 07:54 PM
Harris Todd Head of Corporate Development Apr 25, 2018 Sale $20.00 300 6,000 571,091 Apr 25, 2018, 07:21 PM
Harris Todd Head of Corporate Development Apr 24, 2018 Sale $20.00 150 3,000 571,391 Apr 25, 2018, 07:21 PM
Harris Todd Head of Corporate Development Apr 23, 2018 Sale $20.00 525 10,500 571,541 Apr 25, 2018, 07:21 PM
Harris Todd Head of Corporate Development Apr 17, 2018 Sale $20.00 2,201 44,020 587,876 Apr 19, 2018, 06:00 PM
Harris Todd Head of Corporate Development Apr 18, 2018 Sale $20.09 15,810 317,599 572,066 Apr 19, 2018, 06:00 PM
Harris Todd Head of Corporate Development Apr 10, 2018 Sale $20.02 3,779 75,641 590,077 Apr 12, 2018, 06:45 PM
Harris Todd Head of Corporate Development Apr 09, 2018 Sale $20.00 2,824 56,480 593,856 Apr 09, 2018, 07:18 PM
Harris Todd Head of Corporate Development Apr 05, 2018 Sale $20.00 5,386 107,725 596,680 Apr 09, 2018, 07:18 PM
MORE ROBERT J Director Mar 28, 2018 Sale $18.84 10,000 188,400 193,249 Mar 29, 2018, 08:50 PM
MORE ROBERT J Director Mar 29, 2018 Sale $18.78 14,429 270,977 178,820 Mar 29, 2018, 08:50 PM
Harris Todd Head of Corporate Development Mar 19, 2018 Sale $20.00 5,876 117,520 602,066 Mar 20, 2018, 07:00 PM
Harris Todd Head of Corporate Development Mar 12, 2018 Sale $20.11 3,452 69,429 607,942 Mar 14, 2018, 07:13 PM
Harris Todd Head of Corporate Development Mar 09, 2018 Sale $20.01 2,438 48,784 611,394 Mar 09, 2018, 07:00 PM
Harris Todd Head of Corporate Development Mar 08, 2018 Sale $20.03 14,530 291,097 613,832 Mar 09, 2018, 07:00 PM
Harris Todd Head of Corporate Development Mar 07, 2018 Sale $20.00 3,704 74,080 628,362 Mar 09, 2018, 07:00 PM
FENTON DENNIS M Director Sep 18, 2017 Buy $22.96 1,250 28,698 1,250 Sep 19, 2017, 11:56 AM
Stroehmann Diane See Remarks Aug 01, 2017 Buy $15.00 7,000 105,000 124,724 Aug 01, 2017, 04:27 PM
PETERSON RICHARD D Chief Financial Officer Aug 01, 2017 Buy $15.00 7,000 105,000 7,000 Aug 01, 2017, 04:26 PM
MAST ERLE T Director Aug 01, 2017 Buy $15.00 6,700 100,500 6,700 Aug 01, 2017, 04:24 PM
Lizzul Paul F. Chief Medical Officer Aug 01, 2017 Buy $15.00 10,000 150,000 94,634 Aug 01, 2017, 04:23 PM
Leonard Keith R Director Aug 01, 2017 Buy $15.00 16,700 250,500 16,700 Aug 01, 2017, 04:22 PM
Andrews Timothy K. General Counsel & Secretary Aug 01, 2017 Buy $15.00 15,000 225,000 15,000 Aug 01, 2017, 04:19 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Azoy Alexander Chief Financial Officer 10/02/2019 551
Stroehmann Diane See Remarks 07/02/2019 3,112
Andrews Timothy K. General Counsel & Secretary 07/02/2019 3,112
Lizzul Paul F. Chief Medical Officer 07/02/2019 3,112
Beddingfield III Frederick President & CEO 07/02/2019 12,968
Azoy Alexander Chief Financial Officer 07/02/2019 1,180
ARCH Venture Partners X, LLC 10% Owner 02/22/2019 5,414,500
ARCH Venture Partners VIII, LLC 10% Owner 02/22/2019 5,414,500
Burow Kristina Director 02/22/2019 5,414,500
MORE ROBERT J Director 02/22/2019 250,000
Leonard Keith R Director 02/22/2019 250,000
Beddingfield III Frederick President & CEO 02/22/2019 100,000
Harris Todd Head of Corporate Development 04/30/2018 2,000
Harris Todd Head of Corporate Development 04/25/2018 6,000
Harris Todd Head of Corporate Development 04/24/2018 3,000
Harris Todd Head of Corporate Development 04/23/2018 10,500
Harris Todd Head of Corporate Development 04/17/2018 44,020
Harris Todd Head of Corporate Development 04/18/2018 317,599
Harris Todd Head of Corporate Development 04/10/2018 75,641
Harris Todd Head of Corporate Development 04/09/2018 56,480
Harris Todd Head of Corporate Development 04/05/2018 107,725
MORE ROBERT J Director 03/28/2018 188,400
MORE ROBERT J Director 03/29/2018 270,977
Harris Todd Head of Corporate Development 03/19/2018 117,520
Harris Todd Head of Corporate Development 03/12/2018 69,429
Harris Todd Head of Corporate Development 03/09/2018 48,784
Harris Todd Head of Corporate Development 03/08/2018 291,097
Harris Todd Head of Corporate Development 03/07/2018 74,080
FENTON DENNIS M Director 09/18/2017 28,698
Stroehmann Diane See Remarks 08/01/2017 105,000
PETERSON RICHARD D Chief Financial Officer 08/01/2017 105,000
MAST ERLE T Director 08/01/2017 100,500
Lizzul Paul F. Chief Medical Officer 08/01/2017 150,000
Leonard Keith R Director 08/01/2017 250,500
Andrews Timothy K. General Counsel & Secretary 08/01/2017 225,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2019
06/30/2019
3.96%
1Q
09/30/2019
12/31/2018
39.78%
3Q
09/30/2019
09/30/2018
40.59%
4Q
09/30/2019
06/30/2018
41.10%
5Q
09/30/2019
03/31/2018
41.31%
6Q
Load More

Period of Report: 09/30/2019

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2019
3.96%
1Q
12/31/2018
39.78%
3Q
09/30/2018
40.59%
4Q
06/30/2018
41.10%
5Q
03/31/2018
41.31%
6Q
Load More